{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:10:19Z","timestamp":1781752219437,"version":"3.54.5"},"reference-count":19,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1210\/er.2001-4002","type":"journal-article","created":{"date-parts":[[2002,8,30]],"date-time":"2002-08-30T17:22:48Z","timestamp":1030728168000},"page":"524-528","source":"Crossref","is-referenced-by-count":120,"title":["IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis"],"prefix":"10.1210","volume":"23","author":[{"given":"Ann","family":"Cranney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Zytaruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Osteoporosis Methodology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Osteoporosis Research Advisory Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2019041121505085100_R1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"2019041121505085100_R2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0002-9378(98)70012-2","article-title":"Selective estrogen receptors modulators: a new category of therapeutic agents for extending the health of postmenopausal women.","volume":"179","author":"Goldstein","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121505085100_R3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.7326\/0003-4819-130-5-199903020-00015","article-title":"Clinical effects of raloxifene hydrochloride in women.","volume":"130","author":"Khovidhunkit","year":"1999","journal-title":"Ann Intern Med"},{"key":"2019041121505085100_R4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"key":"2019041121505085100_R5","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women.","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041121505085100_R6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene.","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"2019041121505085100_R7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"The statistical basis of meta-analysis.","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"2019041121505085100_R8","author":"Hedges","year":"1985"},{"key":"2019041121505085100_R9","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0002-9378(97)70091-7","article-title":"Effects of raloxifene hydrochloride on the endometrium of postmenopausal women.","volume":"177","author":"Boss","year":"1997","journal-title":"Am J Gynecol"},{"key":"2019041121505085100_R10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0015-0282(98)00381-1","article-title":"Randomized double-blind placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.","volume":"70","author":"Mijatovic","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041121505085100_R11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650110615","article-title":"A controlled trial of raloxifene HCL: impact on bone turnover and serum lipid profile in healthy postmenopausal women.","volume":"11","author":"Draper","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041121505085100_R12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1359\/jbmr.2002.17.2.341","article-title":"Bone histomorphometric and biochemical marker results of a 2-year randomized, placebo-controlled trial of raloxifene in postmenopausal women.","volume":"17","author":"Ott","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041121505085100_R13","author":"Morii","year":"1998"},{"key":"2019041121505085100_R14","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1359\/jbmr.1998.13.11.1747","article-title":"Treatment of established postmenopausal osteoporosis with raloxifene; a randomized trial.","volume":"13","author":"Lufkin","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2019041121505085100_R15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s001980050236","article-title":"Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.","volume":"10","author":"Meunier","year":"1999","journal-title":"Osteoporosis Int"},{"key":"2019041121505085100_R16","author":"Johnell","year":"1999"},{"key":"2019041121505085100_R17","author":"Pavo","year":"1999"},{"key":"2019041121505085100_R18","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1001\/archinte.160.22.3444","article-title":"Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women.","volume":"160","author":"Johnston Jr","year":"2000","journal-title":"Arch Int Med 160:3444\u20133450 Arch Intern Med"},{"key":"2019041121505085100_R19","first-page":"1437","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med."}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/23\/4\/524\/8860968\/edrv0524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:39:51Z","timestamp":1555069191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/23\/4\/524\/2433274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,11,7]]},"published-print":{"date-parts":[[2002,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2001-4002","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]}}}